mDR Limited Announces Successful Allotment and Listing of Rights Shares and Warrants
Key Highlights
- Allotment of 1.45 Billion Rights Shares and Warrants: mDR Limited has successfully allotted and issued an aggregate of 1,450,183,780 Rights Shares and an equal number of Warrants as part of its renounceable non-underwritten Rights cum Warrants Issue.
- Significant Increase in Share Capital: The total issued and paid-up shares of the Company have surged from 870,110,270 to 2,320,294,050 (excluding treasury shares), representing a substantial dilution and capital base expansion.
- Listing Details:
- The newly issued Rights Shares are expected to be listed and quoted on the Mainboard of the Singapore Exchange Securities Trading Limited (SGX-ST) from 9 a.m. on or about 20 May 2026, with trading commencing at the same time.
- The Warrants are expected to be listed and quoted from 9 a.m. on or about 21 May 2026, with trading commencing simultaneously.
- Parity of Rights Shares: The Rights Shares will rank pari passu with the existing shares in all respects, except for dividends, rights, allotments, or other distributions with a record date prior to the issue date of the Rights Shares.
- Refund for Unsuccessful Applications: Investors who made unsuccessful applications (via CDP) can expect refunds within three (3) market days after trading of the Rights Shares begins.
Investor-Relevant Details and Price-Sensitive Information
- Massive Capital Base Expansion: The Company’s share base has more than doubled, which may have a significant impact on share price due to dilution. Existing shareholders’ proportional ownership will decrease unless they fully subscribed to their Rights Entitlements.
- Potential for Further Dilution: With the issuance of an equal number of Warrants, there is a possibility of future dilution if these Warrants are exercised and converted into ordinary shares.
- Liquidity Considerations: The large increase in the number of shares in issue is likely to boost trading liquidity, but may also put downward pressure on the share price in the short term if there is insufficient demand to absorb the new shares.
- Strategic Use of Proceeds: Although not detailed in this announcement, investors should monitor how the funds raised from this Rights Issue will be utilised, as effective deployment can generate future growth and returns.
- Timing for Trading and Refunds: Investors can begin trading the new shares and warrants from the specified dates, while those with unsuccessful applications will be refunded promptly.
Summary and Outlook
The successful allotment and imminent listing of over 1.45 billion new shares and warrants mark a transformational capital raising event for mDR Limited. This significantly enhances the company’s capital base and provides flexibility for future growth, but also introduces short-term dilution risk for existing shareholders who did not participate in the Rights Issue. The parallel listing of warrants offers an additional instrument for investors to gain exposure to future upside, though it also carries the potential for further dilution upon exercise.
Shareholders and prospective investors should closely monitor the company’s next moves, particularly regarding the deployment of the raised funds and any corporate actions that could further impact the share price.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should perform their own due diligence and consult their financial advisers before making any investment decisions. The information provided is based on the company’s official announcements and may be subject to change.
